Risk of osteoporotic fractures in new users of denosumab compared with new users of alendronate: A Danish populationbased cohort study (Pharmacoepidemiology and Drug Safety, 2018)

(untitled) - Pedersen, AB; Heide-Jorgensen, U; Sorensen, HT; Prieto-Alhambra, D; Ehrenstein, V